The BioPharmaTechnology House SRL
The BioPharmaTechnology House reported total assets of 932,505 € at the end of the 2026 financial year (annual accounts filed with the NBB on 30 Oct 2026).
The score of The BioPharmaTechnology House shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +40 % Total assets +38 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
The BioPharmaTechnology House's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 169,837 € | ||||
| Equity | 639,081 € | ||||
| Cash | 110,198 € | ||||
| EBITDA | 310,563 € | ||||
| Total assets | 932,505 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 30 Oct 2026
- Year ended 31 Mar 2025filed on 30 Oct 2025
- Year ended 31 Mar 2024filed on 31 Oct 2024
- Year ended 31 Mar 2023filed on 29 Oct 2023
- Year ended 31 Mar 2022filed on 31 Oct 2022
The BioPharmaTechnology House's financial analysis
- Solvency68.5%sector median: 60.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of The BioPharmaTechnology House
The BioPharmaTechnology House's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0866.427.061
- VAT number
- BE0866427061
- Peppol
- Registered · 0208:0866427061 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Jul 2004
- Registered office
- 2450 Meerhout
- Latest accounts
- 2026 · filed on 30 Oct 2026
- Activity
- Computer consultancy and computer facilities management activities (NACE 62200)
The BioPharmaTechnology House (SRL) has been based in Meerhout since 2004, active in: computer consultancy and computer facilities management activities. For 2026, it reports a net profit of 169,837 € and equity of 639,081 €; its revenue is not published. Its solvency stands at 68.5%, above the median of its sector (60.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to The BioPharmaTechnology House
Companies in the same business, of comparable size and area, outside its group.
- Genyz Business and other management consultancy activities Incourt · balance sheet €1.47m
- SSIS Computer consultancy and computer facilities management activities Brussels · balance sheet 437,057 €
- T.R.P. Computer consultancy and computer facilities management activities Burdinne · balance sheet 435,082 €
- ND Group Computer consultancy and computer facilities management activities Anderlecht · balance sheet 368,383 €
- Udesite Computer consultancy and computer facilities management activities Sint-Niklaas · balance sheet 158,857 €
Frequently asked questions about The BioPharmaTechnology House
What is the revenue of The BioPharmaTechnology House?
The BioPharmaTechnology House files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of The BioPharmaTechnology House?
In Belgium, the VAT number is the company number prefixed with BE: BE0866427061 for The BioPharmaTechnology House, if the company is VAT-registered. Its company number (CBE) is 0866.427.061.
Where is the registered office of The BioPharmaTechnology House?
According to the CBE register, the registered office of The BioPharmaTechnology House is in 2450 Meerhout.
What is the equity of The BioPharmaTechnology House?
At the close of the 2026 financial year, the equity of The BioPharmaTechnology House amounts to 639,081 €, a solvency of 68.5% of total assets.
Who manages The BioPharmaTechnology House?
The register lists 2 active mandates at The BioPharmaTechnology House. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of The BioPharmaTechnology House
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →